IHC staining for p53 was present in at least 10% of the tumor cell nuclei (positive) in 4 out of 15 of the DTC cases (26.67%, including 3 out of 13 PTC—23.08%—and 1 out of 2 FTC—50%) and in all ATC cases (3 out of 3—100%). Here, TP53 is linked to thyroid cancer, nonmedullary, 2.